Changing gastric cancer treatment in the United States and the pursuit of quality

European Journal of Surgical Oncology

Volumn 31, Issue 6 SPEC. ISS., 2005, Pages 605-615

  Hundahl, Scott A ^a   Wanebo, H J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Chemo radiation; Gastric cancer; Maruyama Index; Outcomes; Quality; Surgery; Surveillance

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID;

ABDOMINAL SURGERY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUING EDUCATION; EXPERIENCE; GASTRECTOMY; GENERAL PRACTITIONER; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; MEDICAL ASSESSMENT; OUTCOMES RESEARCH; PANCREAS RESECTION; PATIENT CARE; PATIENT PARTICIPATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRIVATE PRACTICE; QUALITY CONTROL; SIDE EFFECT; SPLENECTOMY; STOMACH CANCER; SURGICAL TRAINING; TREATMENT OUTCOME; UNITED STATES;

EID: 22144431580     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.02.011     Document Type: Article

References (70)

1. A. Jemal T. Murray A. Samuels A. Ghafoor E. Ward M.J. Thun Cancer statistics, 2003 CA Cancer J Clin 53 1 2003 5-26
2. P.A. Wingo C.J. Cardinez S.H. Landis R.T. Greenlee L.A. Ries R.N. Anderson et al. Long-term trends in cancer mortality in the United States, 1930-1998 Cancer 97 Suppl 12 2003 3133-3275
3. International Agency for Research on Cancer. Cancer incidence in five continents, vol. 8. Lyon: IARC Press; 2002.
4. D.M. Parkin P. Pisani J. Ferlay Global cancer statistics CA Cancer J Clin 49 1 1999 33-64 [see also p. 31]
5. Y. Kodama K. Sugimachi K. Soejima T. Matsusaka K. Inokuchi Evaluation of extensive lymph node dissection for carcinoma of the stomach World J Surg 5 2 1981 241-248
6. K. Maruyama P. Gunven K. Okabayashi M. Sasako T. Kinoshita Lymph node metastases of gastric cancer. General pattern in 1931 patients Ann Surg 210 5 1989 596-602
7. K. Maruyama K. Okabayashi T. Kinoshita Progress in gastric cancer surgery in Japan and its limits of radicality World J Surg 11 4 1987 418-425
8. M.H. Shiu E. Moore M. Sanders A. Huvos B. Freedman J. Goodbold et al. Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis Arch Surg 122 11 1987 1347-1351
9. M.F. Brennan M.S. Karpeh Jr Surgery for gastric cancer: The American view Semin Oncol 23 3 1996 352-359
10. J.W. Smith M.H. Shiu L. Kelsey M.F. Brennan Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma Arch Surg 126 12 1991 1469-1473
11. J.W. Smith M.F. Brennan Surgical treatment of gastric cancer. Proximal, mid, and distal stomach Surg Clin North Am 72 2 1992 381-399
12. D.M. Dent M.V. Madden S.K. Price Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma Br J Surg 75 2 1988 110-112
13. J.J. Bonenkamp J. Hermans M. Sasako C.J. van de Velde Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group N Engl J Med 340 12 1999 908-914
14. J.J. Bonenkamp I. Songun J. Hermans M. Sasako K. Welvaart J.T. Plukker et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 345 8952 1995 745-748
15. A. Cuschieri P. Fayers J. Fielding J. Craven J. Bancewicz V. Joypaul et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet 347 9007 1996 995-999
16. A. Cuschieri S. Weeden J. Fielding J. Bancewicz J. Craven V. Joypaul et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group Br J Cancer 79 9-10 1999 1522-1530
17. C.S. Robertson S.C. Chung S.D. Woods S.M. Griffin S.A. Raimes J.T. Lau et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer Ann Surg 220 2 1994 176-182
18. J.L. Gouzi M. Huguier P.L. Fagniez B. Launois Y. Flamant F. Lacaine et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study Ann Surg 209 2 1989 162-166
19. F. Bozzetti E. Marubini G. Bonfanti R. Miceli C. Piano L. Gennari Subtotal versus total gastrectomy for gastric cancer: Five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group Ann Surg 230 2 1999 170-178
20. K. Maruyama M. Sasako T. Kinoshita T. Sano H. Katai K. Okajima Pancreas-preserving total gastrectomy for proximal gastric cancer World J Surg 19 4 1995 532-536
21. M.F. Brennan Lymph-node dissection for gastric cancer N Engl J Med 340 12 1999 956-958
22. R.C. Martin II D.P. Jaques M.F. Brennan M. Karpeh Extended local resection for advanced gastric cancer: Increased survival versus increased morbidity Ann Surg 236 2 2002 159-165
23. R.C. Martin II D.P. Jaques M.F. Brennan M. Karpeh Achieving RO resection for locally advanced gastric cancer: Is it worth the risk of multiorgan resection? J Am Coll Surg 194 5 2002 568-577
24. H.J. Kim M.S. Karpeh Surgical approaches and outcomes in the treatment of gastric cancer Semin Radiat Oncol 12 2 2002 162-169
25. H.J. Kim M.S. Karpeh Jr M.F. Brennan Standardization of the extent of lymphadenectomy for gastric cancer: Impact on survival Adv Surg 35 2001 203-223
26. J.S. Macdonald S.R. Smalley J. Benedetti et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 10 2001 725-730
27. J.C. Yao P.F. Mansfield P.W. Pisters B.W. Feig N.A. Janjan C. Crane et al. Combined-modality therapy for gastric cancer Semin Surg Oncol 21 4 2003 223-227
28. S.A. Hundahl J.S. Macdonald J. Benedetti T. Fitzsimmons Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment Ann Surg Oncol 9 3 2002 278-286
29. C.G. Moertel L.L. Gunderson J.A. Mailliard P.J. McKenna J.A. Martenson P.A. Burch et al. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group J Clin Oncol 12 1 1994 21-27
30. M.J. O'Connell L.L. Gunderson C.G. Moertel L.K. Kvols A pilot study to determine clinical tolerability of intensive combined modality therapy for locally unresectable gastric cancer Int J Radiat Oncol Biol Phys 11 10 1985 1827-1831
31. H. Bleiberg J.C. Goffin O. Dalesio M. Buyse J.C. Pector M. Gignoux et al. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC Eur J Surg Oncol 15 6 1989 535-543
32. J. Macdonald Treatment of localized gastric cancer Sem Oncol 31 2004 566-573
33. D.P. Kelsen Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116 J Clin Oncol 18 Suppl 21 2000 32S-34S
34. H.J. Wanebo B.J. Kennedy J. Chmiel G. Steele Jr D. Winchester R. Osteen Cancer of the stomach. A patient care study by the American College of Surgeons Ann Surg 218 5 1993 583-592
35. S.A. Hundahl Surgical quality in trials of adjuvant cancer therapy J Surg Oncol 80 4 2002 177-180
36. S.A. Hundahl Surgical quality control in gastric cancer trials Surg Oncol Clin N Am 11 2 2002 445-458
37. R.E. Schwarz Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116 J Clin Oncol 19 6 2001 1879-1880
38. G.H. Kampschoer K. Maruyama C.J. van de Velde M. Sasako T. Kinoshita K. Okabayashi Computer analysis in making preoperative decisions: A rational approach to lymph node dissection in gastric cancer patients Br J Surg 76 9 1989 905-908
39. E. Bollschweiler K. Boettcher A.H. Hoelscher M. Sasako T. Kinoshita K. Maruyama et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: Evaluation of the Maruyama computer program Br J Surg 79 2 1992 156-160
40. S. Guadagni G. de Manzoni M. Catarci M. Valenti G. Amicucci G. De Bernardinis et al. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer World J Surg 24 12 2000 1550-1558
41. J.R. Siewert D. Kelsen K. Maruyama H. Feussner K. Omote M. Etter et al. Gastric cancer diagnosis and treatment - an interactive training program 2000 Spinger Electronic Media [CD-ROM] Berlin
42. Hundahl S, Macdonald J, Benedetti J. Durable survival impact of "Low Maruyama Index Surgery" in trial of adjuvant chemoradiation for gastric cancer. Poster. 2004 ASCO GI Symposium, San Francisco, Jan 22, 2004.
43. Peeters KC, Hundahl SA, Krannenbarg EK, Hartgrink H, van de Velde CJ. Enhanced survival with 'Low-Maruyama-Index' surgery for gastric cancer - a blinded re-analysis of the Dutch D1-D2 Trial. World J Surg [in press].
44. D. Neuhauser Ernest Amory Codman, M.D., and end results of medical care Int J Technol Assess Health Care 6 2 1990 307-325
45. Manual for cancer programs. Chicago: American College of Surgeons; 1954. The current update of this document is Facility oncology data standards (FORDS). Chicago: American College of Surgeons; 2004.
46. M.F. Brennan R.E. Clive D.P. Winchester The COC (Commission on Cancer): its roots and destiny Bull Am Coll Surg 79 6 1994 14-21
47. G.W. Stephenson The Commission on Cancer: An historical review Bull Am Coll Surg 64 9 1979 7-13
48. W. Lawrence Jr The Commission on Cancer and the American Cancer Society: partners in cancer control Bull Am Coll Surg 78 7 1993 19-24
49. H.R. Menck L. Garfinkel G.D. Dodd Preliminary report of the National Cancer Data Base CA Cancer J Clin 41 1 1991 7-18
50. G.P. Murphy The National Cancer Data Base CA Cancer J Clin 41 1 1991 5-6
51. C.J. Mettlin H.R. Menck D.P. Winchester G.P. Murphy A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program Cancer 79 10 1997 2052-2061
52. W. Lawrence Jr H.R. Menck G.D. Steele Jr D.P. Winchester The National Cancer Data Base report on gastric cancer Cancer 75 7 1995 1734-1744
53. S.A. Hundahl H.R. Menck E.G. Mansour D.P. Winchester The National Cancer Data Base report on gastric carcinoma Cancer 80 12 1997 2333-2341
54. S.A. Hundahl J.L. Phillips H.R. Menck The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth edition American Joint Committee on Cancer staging, proximal disease, and the 'different disease' hypothesis Cancer 88 4 2000 921-932
55. H.J. Wanebo B.J. Kennedy D.P. Winchester A. Fremgen A.K. Stewart Gastric carcinoma: Does lymph node dissection alter survival? J Am Coll Surg 183 6 1996 616-624
56. H.J. Wanebo B.J. Kennedy D.P. Winchester A.K. Stewart A.M. Fremgen Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on long term survival J Am Coll Surg 185 2 1997 177-184
57. S.C. Maerki H.S. Luft S.S. Hunt Selecting categories of patients for regionalization. Implications of the relationship between volume and outcome Med Care 24 2 1986 148-158
58. H.S. Luft Hospital volume, physician volume, and patient outcomes: assessing the evidence 1990 Health Administration Press Perspectives Ann Arbor
59. E.L. Hannan M. Radzyner D. Rubin J. Dougherty M.F. Brennan The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer Surgery 131 1 2002 6-15
60. H.S. Luft J.P. Bunker A.C. Enthoven Should operations be regionalized? The empirical relation between surgical volume and mortality N Engl J Med 301 25 1979 1364-1369
61. A. Gandjour A. Bannenberg K.W. Lauterbach Threshold volumes associated with higher survival in health care: A systematic review Med Care 41 10 2003 1129-1141
62. K.W. Kizer The volume-outcome conundrum N Engl J Med 349 22 2003 2159-2161
63. J.D. Birkmeyer T.A. Stukel A.E. Siewers P.P. Goodney D.E. Wennberg F.L. Lucas Surgeon volume and operative mortality in the United States N Engl J Med 349 22 2003 2117-2127
64. J.D. Birkmeyer A.E. Siewers E.V. Finlayson T.A. Stukel F.L. Lucas I Batista et al. Hospital volume and surgical mortality in the United States N Engl J Med 346 15 2002 1128-1137
65. D. Parikh M. Johnson L. Chagla D. Lowe P. McCulloch D2 gastrectomy: lessons from a prospective audit of the learning curve Br J Surg 83 11 1996 1595-1599
66. S.F. Khuri J. Daley W.G. Henderson The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs Arch Surg 137 1 2002 20-27
67. P.P. Goodney A.E. Siewers T.A. Stukel F.L. Lucas D.E. Wennberg J.D. Birkmeyer Is surgery getting safer? National trends in operative mortality J Am Coll Surg 195 2 2002 219-227
68. S.F. Khuri J. Daley W. Henderson K. Hur M. Hossain D. Soybel et al. Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program Ann Surg 230 3 1999 414-429
69. M. Sasako Risk factors for surgical treatment in the Dutch Gastric Cancer Trial Br J Surg 84 11 1997 1567-1571
70. S.R. Smalley L. Gunderson J. Tepper et al. Gastric surgical adjuvant radiotherapy consensus report: Rationale and treatment implementation Int J Radiat Oncol Biol Phys 52 2 2002 283-293